Sinopharm, China's biggest pharmaceuticals distributor, and Metallurgical Corp, one of its biggest engineering groups, have raised a combined $3.5bn in initial public offerings in Hong Kong.
The sales, which collected more than the total value of Hong Kong IPOs in the first half of the year, come as a wave of Chinese companies seek to offer new shares in the territory.
In the past three months, 13 companies have priced IPOs in Hong Kong, while 23 companies have announced their intentions to do so in the coming months.
您已阅读25%（521字），剩余75%（1549字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。